New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
07:22 EDTCFN, CFNCareFusion downgraded to Outperform from Buy at CLSA
CLSA downgraded CareFusion due to valuation. Price target raised to $36 from $30.
News For CFN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
07:17 EDTCFNSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
January 21, 2015
16:48 EDTCFNCareFusion stockholders approve proposed merger with Becton, Dickinson
Becton, Dickinson and Company (BDX) and CareFusion (CFN) announced the results of the CareFusion special meeting of stockholders, held on January 21, for CareFusion stockholders to consider and vote upon the proposed merger of CareFusion and BD. CareFusion stockholders approved the definitive merger agreement and the merger transaction, with approximately 76% of shares outstanding cast in favor of the proposal. As previously announced on October 5, 2014, BD and CareFusion entered into a definitive agreement pursuant to which BD would acquire CareFusion in a stock and cash transaction. CareFusion stockholder approval was a condition to the merger. The proposed acquisition remains subject to certain other conditions and approvals, including approval of the proposed acquisition by the European Commission under the European Union Merger Regulation.
08:00 EDTCFNBecton Dickinson upgraded to Outperform at Cowen
As previously reported, Cowen upgraded Becton Dickinson (BDX) to Outperform from Market Perform as they believe synergy targets for its Carefusion (CFN) acquisition are too low. Cowen raised its price target to $165 form $130 on Becton Dickinson shares.
January 15, 2015
07:59 EDTCFNAmerican Society of Clinical Oncology to hold a symposium
Subscribe for More Information
January 14, 2015
10:24 EDTCFNCareFusion to host special shareholder meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use